We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
AUM
$1.63B
AUM Growth
+$10.2M
Cap. Flow
-$14.5M
Cap. Flow %
-0.89%
Top 10 Hldgs %
17.51%
Holding
808
New
42
Increased
304
Reduced
421
Closed
34
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBR icon
401
Petrobras
PBR
$115B
$825K 0.05%
79,113
+51,353
+185% +$559K
ACV
402
Virtus Diversified Income & Convertible Fund
ACV
$286M
$820K 0.05%
42,472
-2,062
-5% -$42.7K
BSX icon
403
Boston Scientific
BSX
$74.3B
$817K 0.05%
16,331
+11,279
+223% +$532K
TEI
404
Templeton Emerging Markets Income Fund
TEI
$320M
$805K 0.05%
158,825
-54,825
-26% -$296K
APTV icon
405
Aptiv
APTV
$10.2B
$794K 0.05%
7,074
+977
+16% +$108K
MRTX
406
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$792K 0.05%
21,299
+1,536
+8% +$69.1K
JCI icon
407
Johnson Controls International
JCI
$93.4B
$791K 0.05%
13,132
-966
-7% -$61.9K
STX icon
408
Seagate
STX
$200B
$790K 0.05%
11,955
-162
-1% -$10.3K
ATRA icon
409
Atara Biotherapeutics
ATRA
$80.9M
$781K 0.05%
10,766
-322
-3% -$31.2K
SWTX
410
DELISTED
SpringWorks Therapeutics
SWTX
$779K 0.05%
30,251
+5,133
+20% +$150K
CMS icon
411
CMS Energy
CMS
$22B
$770K 0.05%
12,547
+2,408
+24% +$148K
MDLZ icon
412
Mondelez International
MDLZ
$79.1B
$761K 0.05%
10,925
-459
-4% -$30.4K
SQM icon
413
Sociedad Química y Minera de Chile
SQM
$20.4B
$761K 0.05%
9,387
+5,326
+131% +$459K
TSN icon
414
Tyson Foods
TSN
$19.6B
$761K 0.05%
12,827
-2,457
-16% -$151K
REGN icon
415
Regeneron Pharmaceuticals
REGN
$82B
$759K 0.05%
924
-1,152
-55% -$869K
MSD
416
Morgan Stanley Emerging Markets Debt Fund
MSD
$148M
$752K 0.05%
116,721
-1,656
-1% -$11.1K
APLS
417
DELISTED
Apellis Pharmaceuticals
APLS
$748K 0.05%
11,346
+1,928
+20% +$111K
CAT icon
418
Caterpillar
CAT
$398B
$748K 0.05%
3,270
+23
+0.7% +$5.56K
VKQ icon
419
Invesco Municipal Trust
VKQ
$544M
$742K 0.05%
+74,841
New +$731K
KNSA icon
420
Kiniksa Pharmaceuticals
KNSA
$6.15B
$741K 0.05%
68,881
-10,538
-13% -$139K
DSL
421
DoubleLine Income Solutions Fund
DSL
$1.23B
$740K 0.05%
65,056
+27,981
+75% +$334K
RSG icon
422
Republic Services
RSG
$66.4B
$739K 0.05%
5,463
+3,052
+127% +$389K
TRIN icon
423
Trinity Capital Inc.
TRIN
$1.73B
$738K 0.05%
57,952
+40,832
+239% +$535K
PHT
424
DELISTED
Pioneer High Income Fund
PHT
$735K 0.05%
110,816
-975
-0.9% -$6.68K
VIR icon
425
Vir Biotechnology
VIR
$1.53B
$735K 0.05%
31,573
+5,358
+20% +$137K

Similar funds

Hennion & Walsh Asset Management's Q1 2023 Portfolio in Review

As of Q1 2023, Hennion & Walsh Asset Management held 808 positions worth $1.63B, up 0.63% from $1.62B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Hennion & Walsh Asset Management's Q1 2023 filing shows 42 new, 304 increased, 421 reduced and 34 closed positions. Its largest new stake was WisdomTree International Quality Dividend Growth Fund: 667,358 shares worth $22.6M. The largest sale was iShares Core S&P 500 ETF, an estimated $11.4M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 14% a quarter earlier, followed by Financials and Technology.

  • Hennion & Walsh Asset Management's largest Q1 2023 buy was WisdomTree International Quality Dividend Growth Fund: 667,358 shares worth $22.6M.
  • Hennion & Walsh Asset Management added most to Nuveen Quality Municipal Income Fund in Q1 2023, an estimated $3.98M increase.
  • Hennion & Walsh Asset Management's biggest Q1 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $11.4M.
  • Hennion & Walsh Asset Management fully exited iShares International Equity Factor ETF in Q1 2023, selling an estimated $9.4M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 18% of its $1.63B portfolio in Q1 2023.
  • Hennion & Walsh Asset Management opened 42 new positions and closed 34 in Q1 2023.
  • Hennion & Walsh Asset Management's portfolio value rose 0.63% quarter-over-quarter to $1.63B.

Based on Hennion & Walsh Asset Management's 13F filing for Q1 2023, filed 20 Apr 2023.